Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline and Rifampicin in Alzheimer's Disease
NCT00439166Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Feb 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of doxycycline and rifampicin in Alzheimer's disease (AD), sponsored by Hamilton Health Sciences. Started Feb 2007; status: completed.
02
Drugs
doxycyclinerifampicin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00439166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439166.